AAAAAA

   
Results: 1-7 |
Results: 7
Effects of once-daily angiotensin-converting enzyme inhibition and calciumchannel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension - The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial
Authors: Devereux, RB Palmieri, V Sharpe, N De Quattro, V Bella, JN de Simone, G Walker, JF Hahn, RT Dahlof, B
Citation: Rb. Devereux et al., Effects of once-daily angiotensin-converting enzyme inhibition and calciumchannel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension - The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial, CIRCULATION, 104(11), 2001, pp. 1248-1254
A t(2;19)(p13;p13.2) in a giant invasive cardiac lipoma from a patient with multiple lipomatosis
Authors: Vaughan, CJ Weremowicz, S Goldstein, MM Casey, M Hart, M Hahn, RT Devereux, RB Girardi, L Schoen, FJ Fletcher, JA Morton, CC Basson, CT
Citation: Cj. Vaughan et al., A t(2;19)(p13;p13.2) in a giant invasive cardiac lipoma from a patient with multiple lipomatosis, GENE CHROM, 28(2), 2000, pp. 133-137
Left ventricular geometry and function preceding neurally mediated syncope
Authors: Liu, JE Hahn, RT Stein, KM Markowitz, SM Okin, PM Devereux, RB Lerman, BB
Citation: Je. Liu et al., Left ventricular geometry and function preceding neurally mediated syncope, CIRCULATION, 101(7), 2000, pp. 777-783
Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121
Authors: Patel, SR Lee, LY Mack, CA Polce, DR El-Sawy, T Hackett, NR Ilercil, A Jones, EC Hahn, RT Isom, OW Rosengart, TK Crystal, RG
Citation: Sr. Patel et al., Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121, HUM GENE TH, 10(8), 1999, pp. 1331-1348
Echocardiographic and survival studies in mice undergoing endotoxic shock:Effects of genetic ablation of inducible nitric oxide synthase and pharmacologic antagonism of platelet-activating factor
Authors: Nicholson, SC Hahn, RT Grobmyer, SR Brause, JE Hafner, A Potter, S Devereux, RB Nathan, CF
Citation: Sc. Nicholson et al., Echocardiographic and survival studies in mice undergoing endotoxic shock:Effects of genetic ablation of inducible nitric oxide synthase and pharmacologic antagonism of platelet-activating factor, J SURG RES, 86(2), 1999, pp. 198-205
Angiogenesis gene therapy - Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
Authors: Rosengart, TK Lee, LY Patel, SR Sanborn, TA Parikh, M Bergman, GW Hachamovitch, R Szulc, M Kligfield, PD Okin, PM Hahn, RT Devereux, RB Post, MR Hackett, NR Foster, T Grasso, TM Lesser, ML Isom, OW Crystal, RG
Citation: Tk. Rosengart et al., Angiogenesis gene therapy - Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease, CIRCULATION, 100(5), 1999, pp. 468-474
Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE study)
Authors: Palmieri, V Bella, JN DeQuattro, V Roman, MJ Hahn, RT Dahlof, B Sharpe, N Lau, CP Chen, WC Paran, E de Simone, G Devereux, RB
Citation: V. Palmieri et al., Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE study), AM J CARD, 84(5), 1999, pp. 558-562
Risultati: 1-7 |